{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:01:51Z","timestamp":1780038111615,"version":"3.53.1"},"reference-count":0,"publisher":"AME Publishing Company","issue":"5","content-domain":{"domain":["amegroups.com"],"crossmark-restriction":false},"short-container-title":["Transl Cancer Res"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.21037\/tcr-2026-1-0413","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:21:26Z","timestamp":1779351686000},"page":"368-368","update-policy":"https:\/\/doi.org\/10.21037\/ame_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Defining the biological boundaries of daratumumab monotherapy: long-term insights from the CENTAURUS trial in high-risk smoldering multiple myeloma"],"prefix":"10.21037","volume":"15","author":[{"given":"Katsuhiro","family":"Miura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8611","published-online":{"date-parts":[[2026,5]]},"container-title":["Translational Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/tcr.amegroups.com\/article\/download\/117636\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:05:36Z","timestamp":1780034736000},"score":1,"resource":{"primary":{"URL":"https:\/\/tcr.amegroups.com\/article\/view\/117636\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":0,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]},"published-print":{"date-parts":[[2026,5]]}},"URL":"https:\/\/doi.org\/10.21037\/tcr-2026-1-0413","relation":{},"ISSN":["2218-676X","2219-6803"],"issn-type":[{"value":"2218-676X","type":"print"},{"value":"2219-6803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}